National Medical Care Co. · TADAWUL:4005
National Medical Care — FY2024 Earnings Presentation
20 slides from National Medical Care's earnings presentation, Feb 25, 2025
Slide 1: Earnings Presentation FY 2024
Earnings Presentation FY 2024 25 February, 2025
Slide 2: Performance Highlights and Strategy
Performance Highlights and Strategy Care Medical Earnings Presentation – 25/02/25 2
Slide 3: Delivering Strong Financial and Operational Results in FY 2024
Delivering Strong Financial and Operational Results in FY 2024 Operating and financial performance highlights Revenue FY 2024 1,294 742.5 Total FY 2024 patients New branches AlBalad Haram Al Salam thousand +14% year-on-year 1,294 SAR mn +20% year-on-year 720.3 FY 2024 Outpatients1 • Jeddah, KSA • Lo
Slide 4: Strategic Focus: Expansion, New Services, Efficiency, and Automation
Strategic Focus: Expansion, New Services, Efficiency, and Automation Overview of strategic initiatives New Services Home Healthcare Services Executive Health Check ReLib Mental Health Center Started Home Healthcare Services to increase Launched executive health check to raise cash Introduced mental
Slide 5: Al Salam Hospital
Al Salam Hospital A C-class facility providing a broad range of healthcare services acquired in October 2024 Hospital Overview 44 Acquisition Price Revenue (SAR mn) SAR mn 7.8 Name: Al Salam Hospital Location: Riyadh 100 Full Capacity 4.5 5.6 Beds1 Services: Broad-Scope Healthcare Status: Operationa
Slide 6: Operating and Financial Performance
Operating and Financial Performance Care Medical Earnings Presentation – 25/02/25 6
Slide 7: Operational Trends
Operational Trends Growing patient numbers supported by new branches and increased referrals from key clients Operational Highlights1,2 Inpatients Admissions Quarterly Trend SAR mn FY 2024 FY 2023 YoY, % FY 2024 LfL YoY, % (Admissions) Inpatient admissions 22,139 21,280 +4% 20,544 -3% +34% Outpatien
Slide 8: Income Statement
Income Statement Driving margin improvements with strong revenue and cost discipline Income Statement Highlights Net Profit Development SAR mn 4Q2024 4Q2023 YoY, % FY 2024 FY 2023 YoY, % (SAR mn) Revenues 373 300 +24% 1,294 1,082 +20% Cost of revenues (248) (193) +29% (840) (712) +18% +24% Gross pro
Slide 9: Revenue Trends
Revenue Trends Revenue in 2024 supported by growing number of referrals and contribution of the new branches Revenue Development1 Revenue by Business Unit (FY 2024) (SAR mn) (SAR mn) 4 +20% 4 3 28 2 0 1,294 3 Malaz branch, 41.0% 74 2 SAR 1,294mn Rawabi branch, 48.9% 2 1 107 1 AlBalad branch, 8.1% 0
Slide 10: Costs Overview
Costs Overview Driving operating leverage as revenue outpaces expense growth Total Expenses Breakdown (FY 2024) Cost of Revenues Breakdown (FY 2024) +19% (SAR mn) (SAR mn) 4 64.3% Operating expenses, 15.8% Salaries & benefits 4 FY 2024 YoY 3 25.1% 3 Medicines & consumables 1.8% 2 SAR 997mn Repairs &
Slide 11: Balance Sheet Highlights
Balance Sheet Highlights Strong balance sheet supported by solid cash reserves and improving cash conversion cycle Balance Sheet Highlights Cash Conversion Cycle1 Trend SAR mn 4Q2024 4Q2023 YtD, % (Days) Total Non-Current Assets 1,273 936 +36% Total Current Assets 1,229 1,278 -4% Total Assets 2,502
Slide 12: Receivables Management
Receivables Management Trade receivables growth driven by insurance segment and GOSI referrals Trade Receivables1 Development Trade Receivables1 Structure (end of 4Q 2024) (SAR mn) (SAR mn) 31.3% Insurance +42% 30.7% MoH & Govt 94 24 934 27.8% 7 GOSI 4.7% Cash 169 (20) 5.5% Other 659 Trade Receivabl
Slide 13: Cash Flow Highlights
Cash Flow Highlights Stronger results support cash flow, counterbalanced by working capital increase Cash Flow Highlights Cash Flow From Operations Development SAR mn 4Q2024 4Q2023 YoY, % FY 2024 FY 2023 YoY, % (SAR mn) Net Profit before zakat 85 62 +37% 294 265 +11% 29 84 Non-cash adjustments 53 20
Slide 14: Q&A Session
Q&A Session Care Medical Earnings Presentation – 25/02/25 14
Slide 15: Appendix
Appendix Care Medical Earnings Presentation – 25/02/25 15
Slide 16: Operating Performance Overview (1/2)
Operating Performance Overview1 (1/2) Total Patients Trend Surgeries Trend (Thousand patients) (Thousand surgeries) +20% CAGR +11% CAGR 742 19 19 20 639 651 16 532 55 362 13 254 253 261 193 136 339 385 398 427 227 FY20 +47% FY21 +20% FY22 +2% FY23 +14% FY24 Rawabi branch Malaz branch Other 2 FY20 +2
Slide 17: Operating Performance Overview (2/2)
Operating Performance Overview1 (2/2) Bed Capacity Trend Bed Occupancy Trend (Available beds) (%) +15% CAGR 80.3% 79.2% 77.6% 1,128 655 655 655 655 349 70.8% 335 335 335 335 459 68.1% 320 320 320 320 320 FY20 +0% FY21 +0% FY22 +0% FY23 +72% FY24 FY20 FY21 FY22 FY23 FY24 Rawabi branch Malaz branch Ot
Slide 18: Financial Performance Overview
Financial Performance Overview Total Revenue Trend EBITDA Trend (SAR mn) (SAR mn) +12% CAGR +20% CAGR 1,294 377 1,082 302 845 918 243 809 214 179 FY20 +5% FY21 +9% FY22 +18% FY23 +20% FY24 FY20 +19% FY21 +13% FY22 +24% FY23 +25% FY24 Net Profit Trend Margins Trend (SAR mn) (%) +32% CAGR 35.1% 298 27
Slide 19: Contacts
Contacts Institutional investor contact Alia Balbaa Investor Relations Director abalbaa@care.med.sa +966-11-418-4488 ext. 322 Investor Relations website https://ir.care.med.sa/ Care Medical Earnings Presentation – 25/02/25 19
Slide 20: Disclaimer
Disclaimer All information included in this document is for general use only and has not been independently verified, nor does it constitute or form part of any invitation or inducement to engage in any investment activity, nor does it constitute an offer or invitation or recommendation to buy or su
National Medical Care Co. (CARE) — FY2024 Earnings Presentation on 6ix